A former employee of Stanford University was found guilty of accessing a clinical research database for a multisite breast ...

More widespread use of mammograms, along with the implementation of targeted hormone therapies more than 40 years ago, has ...

ASCO’s updated guidelines for advanced ovarian cancer emphasize health equity and provide new recommendations for HIPEC while ...

Study cohort began collecting data on newborns through adulthood, and may offer objective clues on asthma and COPD disease ...

Recently approved treatments for generalized myasthenia gravis (gMG), including complement and neonatal Fc receptor (FcRn) ...

Good morning. Shortly after he became CEO of Bayer AG in 2023, CEO Bill Anderson began waging war against bureaucracy to make ...

As we enter 2025, the confluence of scientific advancement, market opportunity and industry validation suggests women's ...

Genentech and Novartis have teamed up with Food Allergy Research & Education (FARE) to enhance the safety of children with ...

Roche's drug portfolio shows promise, but mixed indicators reveal uncertainties. Check out the risks, opportunities, and ...

Roche’s U.S. biotech subsidiary Genentech has wiped its website of past diversity reports as the company’s diversity and ...

CAMBRIDGE, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining ...